Search

Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines

There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.

Newmedica strengthens glaucoma services with optometrist-turned-ophthalmologist appointment

Newmedica, a leading provider of ophthalmology services across England, has appointed Richard Stead as its lead for glaucoma. This strategic move underscores Newmedica's commitment to delivering exceptional and timely care for both NHS and private patients across the spectrum of...

Landmark review of glaucoma treatment and research published by Moorfields-led team

Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.

Moorfields surgeons save the sight of 24 wounded Bangladeshi students

Moorfields Eye Hospital consultant ophthalmologists Mahi Muqit and Niaz Islam were invited to Dhaka by Bangladesh’s interim government to help 120 patients with bullet wounds to their eyes. Their injuries were a result of their involvement in protests against the...

Survey reveals poor public awareness of dry eye disease

A new survey has revealed how few people are aware of Dry Eye Disease, a debilitating and painful eye condition which affects one in four people in the UK.

WATCH EPISODE 12: Beyond 2020 with the Andean Medical Mission

Welcome to the 12th episode of Beyond 2020, the video series from Andean Medical Mission | Bolivian Medical Charity that looks at strategies to eliminate avoidable blindness in countries with developing eyecare services and shares ideas and solutions to common...

UK-EGG Seedcorn award call now open

The UK Eye Genetics Group is now accepting applications for a new Seedcorn Award, offering up to £5,000, to support early career researchers in conducting innovative projects focused on the diagnosis, understanding, prevention, management and treatment of genetic eye diseases....

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

The gift of family

“Your kids look just like you!” is an oft-heard phrase at family gatherings. Setting aside the obvious explanation of basic genetics, similarities and recurrent character traits are well recognised within a family unit. Shared positive mutual experiences shape these attitudes...

The Qatar Fund for Development and Orbis to Launch Qatar Creating Vision in Ethiopia

The Qatar Fund for Development (QFFD) are providing funding to international eye care charity Orbis, to launch the Qatar Creating Vision initiative Ethiopia.

Launch of the Vision and eye screening implementation handbook

The WHO Vision and Eye Care Programme has the pleasure to announce the publication of the Vision and eye screening implementation handbook (VESIH).

Good news: new study links moderate wine consumption to lower risk of cataract surgery

An observational study published today in Ophthalmology (the journal of the American Academy of Ophthalmology) indicates that low to moderate alcohol consumption is associated with a lower risk of requiring surgery for cataracts, although the nature of the study means it does not definitively prove a direct causal effect.